# Bank of America to Spend $250 Million Annually on GLP-1 Drugs 2026-08-06T14:38:33+00:00 | Business & Economy | Indian Opinion Desk Corroboration: 1 independent outlet Bank of America plans to spend $250 million a year on GLP-1 medicines, NDTV Profit reports. The drugs include Ozempic and Wegovy, which have seen rising demand. Each patient’s treatment can cost employers in the United States thousands of dollars a year, putting pressure on company expenses. The report describes Bank of America’s spending as a good investment, but does not provide further details on the policy or expected returns. ## Coverage - ndtvprofit.com Tags: Bank of America, GLP-1 drugs, Ozempic, US healthcare, Wegovy Canonical: https://indianopinion.org/bank-of-america-to-spend-250-million-annually-on-glp-1-drugs/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/bank-of-america-to-spend-250-million-annually-on-glp-1-drugs/#story-in-brief Review state: restored archive article, accurate at time of publication, not offered to search indexes.